Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Nordion
Some 50 experts and executives in the biopharma sector shared their views on the major trends they expect to see driving change in the clinical trials arena in 2024. Artificial intelligence applied to clinical development, greater use of remote monitoring and increased patient diversity in trials were key themes.
Public Company Edition: Discussions at the J.P. Morgan Healthcare Conference 8-11 January in San Francisco should offer some insight on industry’s and investors’ expectations about the financial markets in 2024. The year started with some big financings, but also some new job cuts.
Excitement continues to grow around pelabresib after the presentation of promising data for the German group’s myelofibrosis drug.
The jury is out on whether regulators have seen enough to approve pelabresib.
- Medical Devices
- Other Names / Subsidiaries
- MDS Inc.
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.